Sarcopenia

What it is

Sarcopenia is age-related loss of muscle strength and mass that can begin as early as the 4th decade of life. It is now treated as a muscle disease, not just a normal part of ageing, because it raises the risk of falls, frailty, disability, hospitalization, and loss of independence. Current expert guidance places low muscle strength first in diagnosis, because strength predicts poor outcomes better than muscle mass alone.

In practical terms, sarcopenia means muscles become smaller, weaker, and less able to support daily tasks such as climbing stairs, rising from a chair, carrying groceries, or walking at a usual pace. It is most common in older adults, but it can also occur earlier in people with chronic illness, low physical activity, undernutrition, prolonged bed rest, or inflammatory disease. In India, this matters because older adults may have low protein intake, low vitamin D status, and reduced activity after illness, all of which can worsen muscle loss.

A commonly used framework from the European Working Group on Sarcopenia in Older People, updated in 2018, describes sarcopenia in stages:

Stage	Main feature
Probable sarcopenia	Low muscle strength
Confirmed sarcopenia	Low strength plus low muscle quantity or quality
Severe sarcopenia	Low strength, low muscle quantity/quality, and low physical performance

How it works

Sarcopenia develops over years through several overlapping biological changes. Ageing muscle shows both muscle fibre atrophy and loss of muscle fibres, especially fast-twitch fibres that are important for power and balance. Nerve supply to muscle also declines, and some motor units are lost and not fully replaced.

Another key mechanism is anabolic resistance. This means older muscle responds less strongly to normal triggers for muscle building, especially dietary protein and exercise. As a result, the same meal or activity that once maintained muscle may no longer be enough. Hormonal changes, chronic low-grade inflammation, insulin resistance, mitochondrial dysfunction, and reduced physical activity can all add to this process.

Common contributors include:

1. Ageing itself
2. Physical inactivity or prolonged bed rest
3. Low protein or calorie intake
4. Chronic diseases such as cancer, COPD, heart failure, kidney disease, and diabetes
5. Low vitamin D status in some people
6. Acute illness, surgery, or hospitalization

Sarcopenia can overlap with frailty, osteoporosis, and obesity. Some people have sarcopenic obesity, meaning low muscle with excess body fat. In these cases, body weight alone can hide the problem.

Evidence and uses

The main reason sarcopenia matters is that it predicts clinically important outcomes. Studies consistently link it with slower walking speed, poorer balance, more falls, fractures, disability, and higher mortality. It can also affect recovery after surgery or hospitalization.

The strongest evidence for treatment supports progressive resistance exercise, such as supervised or home-based strength training using weights, resistance bands, or body weight. This can improve muscle strength and physical performance, and often helps even in very old adults.

Nutrition also matters, especially adequate total energy and protein intake. Older adults with low intake may benefit from improving dietary protein distribution across meals. In India, this may require attention in people whose diets are cereal-heavy and relatively low in high-quality protein foods such as pulses, dairy, eggs, fish, or soy. Some studies suggest vitamin D replacement helps when deficiency is present, but vitamin D is not a stand-alone treatment for sarcopenia.

Evidence for drugs is limited. No medicine is universally accepted as standard treatment specifically for sarcopenia in routine practice. Testosterone and other anabolic approaches have been studied, but benefits must be weighed against risks and they are not appropriate for general use without medical supervision. Research on amino acids, HMB, creatine, and other supplements is ongoing, but results are mixed and often depend on whether exercise is included.

A practical treatment approach often includes:

Intervention	What evidence suggests
Resistance training	Best-supported intervention for strength and function
Adequate protein and calories	Important, especially if intake is low
Vitamin D correction	Useful when deficiency exists
Balance and gait training	Helps reduce fall risk in some people
Treating underlying illness	Important if sarcopenia is secondary to disease

Diagnosis / how it's measured

Diagnosis does not rely on appearance alone. A person can look thin, normal-weight, or overweight and still have sarcopenia. Screening often starts with symptoms or a questionnaire such as SARC-F, which asks about strength, walking, rising from a chair, climbing stairs, and falls.

Formal assessment usually follows a stepwise pattern:

1. Muscle strength: often measured by handgrip strength or chair-stand testing
2. Muscle quantity or quality: assessed by DXA, bioelectrical impedance analysis, CT, or MRI depending on setting
3. Physical performance: measured by gait speed, Short Physical Performance Battery, Timed Up and Go, or similar tests

According to the 2018 European consensus, low muscle strength suggests probable sarcopenia, while low strength plus low muscle mass or quality confirms it. Poor physical performance indicates severe sarcopenia.

Doctors may also look for causes or related problems, including malnutrition, thyroid disease, inflammatory illness, kidney disease, low vitamin D, neurologic disease, or medication effects. There is no single blood test that diagnoses sarcopenia.

When to see a clinician

See a clinician if you or an older family member has noticeable weakness, repeated falls, slower walking, trouble getting up from a chair, unintentional weight loss, or decline after hospitalization. These symptoms are not always “just ageing.” They can reflect sarcopenia, frailty, malnutrition, neurologic disease, or another treatable condition.

Medical review is especially important if weakness develops quickly, affects one side more than the other, comes with pain, fever, numbness, swallowing trouble, or shortness of breath, or follows a major illness. A clinician may involve a geriatrician, physiotherapist, dietitian, or rehabilitation specialist.

Limitations and open questions

Sarcopenia is a useful clinical concept, but diagnosis is still not perfectly standardized across countries and care settings. Different studies use different cutoffs for grip strength, muscle mass, and walking speed, which makes prevalence estimates vary.

Another limitation is that muscle quality is harder to measure than muscle quantity, yet it may matter greatly for function. Access to DXA, CT, or MRI is uneven, especially in routine community care. Simpler tools such as SARC-F and chair-stand tests are practical, but they are not perfect.

Evidence is strongest for exercise, but less certain for supplements and medicines. Many nutrition trials are small, short, or include mixed populations, so it is not always clear who benefits most. Researchers are still studying the best protein targets, the role of leucine or HMB, how to manage sarcopenic obesity, and whether future drugs can safely improve muscle function.

For now, the most reliable approach is early recognition, strength-focused exercise, adequate nutrition, fall-risk reduction, and treatment of underlying disease rather than assuming muscle loss is unavoidable.